0001104659-26-017298
SEC filingTraws Pharma, Inc. filed an 8-K on February 19, 2026, under Item 8.01 disclosing information in Exhibit 99.1 Press Release and Item 9.01 listing exhibits. The filing contains forward-looking statements involving substantial risks and uncertainties.